Tagged with Shanghai Pharma

China: Sciwind Confirms Obesity Ambitions with Positive Phase III Readout; FDA Blocks Cell Exports to China

China China: Sciwind Confirms Obesity Ambitions with Positive Phase III Readout; FDA Blocks Cell Exports to China

China A summary of top stories from China’s pharma industry: Sciwind Biosciences presents promising trial data for its obesity contender; Simcere reaches approval for its Idorsia-partnered insomnia therapy; AstraZeneca inks AI-enabled research deal with CSPC Pharmaceuticals, and the FDA blocks clinical trials that export American’s cells to China. Sciwind’s GLP‑1 data…